Effect of a 188Re-SSS lipiodol/131I-lipiodol mixture, 188Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Effect of a 188Re-SSS lipiodol/131I-lipiodol mixture, 188Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma

Published:2006-04 Issue:4 Volume:27 Page:363-369
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Garin Elienne,Rakotonirina Hervé,Lejeune Florence,Denizot Benoit,Roux Jerome,Noiret Nicolas,Mesbah Habiba,Herry Jean-Yues,Bourguet Patrick,Lejeune Jean-Jacques

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference33 articles.

1. Epidemiology of Primary Liver Cancer

2. Lipiodol solution of a lipophilic agent, 188Re-TDD, for the treatment of liver cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy;Journal of the ICRU;2021-12

2. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization;European Journal of Nuclear Medicine and Molecular Imaging;2019-02-04

3. Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: Trans-arterial radio-embolisation of HCC;Cancer Treatment Reviews;2012-10

4. Antibody-Targeted Therapeutic Radionuclides in the Management of Colorectal Cancer;Nuclear Medicine Therapy;2012-07-19

5. Rhenium-188: Availability from the 188W/188Re Generator and Status of Current Applications;Current Radiopharmaceuticals;2012-06-01